Market Closed -
Bombay S.E.
06:00:49 2024-05-30 am EDT
|
5-day change
|
1st Jan Change
|
3,538
INR
|
-0.52%
|
|
-6.26%
|
-7.41%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
12,671
|
9,132
|
8,340
|
8,375
|
9,086
|
12,289
|
Enterprise Value (EV)
1 |
11,952
|
8,208
|
7,229
|
7,012
|
7,595
|
10,401
|
P/E ratio
|
40.5
x
|
28.5
x
|
24.2
x
|
54.3
x
|
27.8
x
|
26.7
x
|
Yield
|
1.26%
|
1.75%
|
1.15%
|
1.14%
|
1.76%
|
1.3%
|
Capitalization / Revenue
|
3.58
x
|
2.52
x
|
2.59
x
|
3.31
x
|
2.69
x
|
3.02
x
|
EV / Revenue
|
3.38
x
|
2.27
x
|
2.24
x
|
2.77
x
|
2.25
x
|
2.56
x
|
EV / EBITDA
|
23
x
|
16
x
|
14.8
x
|
29.7
x
|
17.1
x
|
16
x
|
EV / FCF
|
22.4
x
|
20.8
x
|
22.5
x
|
24.4
x
|
99.4
x
|
23.6
x
|
FCF Yield
|
4.46%
|
4.82%
|
4.44%
|
4.1%
|
1.01%
|
4.24%
|
Price to Book
|
8.7
x
|
5.85
x
|
4.87
x
|
4.59
x
|
4.35
x
|
5.14
x
|
Nbr of stocks (in thousands)
|
6,386
|
6,386
|
6,386
|
6,386
|
6,386
|
6,386
|
Reference price
2 |
1,984
|
1,430
|
1,306
|
1,311
|
1,423
|
1,924
|
Announcement Date
|
4/26/18
|
3/30/19
|
8/18/20
|
5/28/21
|
4/7/22
|
4/28/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
3,540
|
3,622
|
3,225
|
2,528
|
3,380
|
4,067
|
EBITDA
1 |
520.2
|
513.9
|
488.5
|
236.3
|
443.4
|
649.4
|
EBIT
1 |
469.9
|
468.6
|
446.6
|
177.2
|
384.6
|
560.4
|
Operating Margin
|
13.27%
|
12.94%
|
13.85%
|
7.01%
|
11.38%
|
13.78%
|
Earnings before Tax (EBT)
1 |
477.8
|
500.7
|
496.3
|
210.9
|
433.2
|
613.3
|
Net income
1 |
313.2
|
320.4
|
345.3
|
154.4
|
326.7
|
459.7
|
Net margin
|
8.85%
|
8.85%
|
10.71%
|
6.11%
|
9.67%
|
11.3%
|
EPS
2 |
49.04
|
50.16
|
54.07
|
24.17
|
51.16
|
71.98
|
Free Cash Flow
1 |
533.6
|
395.5
|
320.7
|
287.3
|
76.38
|
441.5
|
FCF margin
|
15.07%
|
10.92%
|
9.94%
|
11.37%
|
2.26%
|
10.85%
|
FCF Conversion (EBITDA)
|
102.57%
|
76.95%
|
65.63%
|
121.58%
|
17.23%
|
67.98%
|
FCF Conversion (Net income)
|
170.36%
|
123.44%
|
92.85%
|
186.15%
|
23.38%
|
96.04%
|
Dividend per Share
2 |
25.00
|
25.00
|
15.00
|
15.00
|
25.00
|
25.00
|
Announcement Date
|
4/26/18
|
3/30/19
|
8/18/20
|
5/28/21
|
4/7/22
|
4/28/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
719
|
924
|
1,111
|
1,363
|
1,492
|
1,887
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
534
|
395
|
321
|
287
|
76.4
|
441
|
ROE (net income / shareholders' equity)
|
23.2%
|
21.2%
|
21.1%
|
8.72%
|
16.7%
|
20.5%
|
ROA (Net income/ Total Assets)
|
14.5%
|
12.7%
|
11.5%
|
4.33%
|
8.62%
|
11%
|
Assets
1 |
2,154
|
2,513
|
3,013
|
3,566
|
3,789
|
4,197
|
Book Value Per Share
2 |
228.0
|
244.0
|
268.0
|
286.0
|
327.0
|
374.0
|
Cash Flow per Share
2 |
114.0
|
145.0
|
174.0
|
213.0
|
234.0
|
295.0
|
Capex
1 |
28.6
|
80.6
|
137
|
44.2
|
54.7
|
80.5
|
Capex / Sales
|
0.81%
|
2.23%
|
4.23%
|
1.75%
|
1.62%
|
1.98%
|
Announcement Date
|
4/26/18
|
3/30/19
|
8/18/20
|
5/28/21
|
4/7/22
|
4/28/23
|
|
1st Jan change
|
Capi.
|
---|
| -7.41% | 273M | | +1.84% | 101B | | -9.58% | 60.39B | | +74.29% | 48.94B | | +17.72% | 39.17B | | +1.83% | 31.53B | | +11.97% | 20.15B | | +12.59% | 16.78B | | +11.16% | 14.22B | | +0.19% | 13.69B |
Other Commodity Chemicals
|